|Day Low/High||615.50 / 628.57|
|52 Wk Low/High||70.10 / 884.49|
CRBP has topline Phase 3 data for its primary compound Lenabasum for Systemic Sclerosis due out this summer.
* Will the Embassy tit for tat be the nail in the market (that many haven't been looking at) and be the catalyst for the market's relentless advance from March to end? * Yesterday's outside day may have been a dark moment in time for the markets and...
FATMAANN names are leading to the downside, but small-caps and value are outperforming.
Plus, why shares of vaccine maker Moderna are taking a hit.
Typically, when leading names correct, the entire market will fall in tandem, but here's what's happening this time.
Investors might have to take it on the chin -- and then do some soul searching -- as names like Microsoft, Tesla and other stars get hit.
There are opportunities but you better be selective and move fast.
Microsoft is awesome and so is their CEO, and I have serious thoughts on Tesla.
* In pre-market trading at $1642 * I have been waiting patiently to short Tesla for years * Tesla goes on my Best Ideas List (short) Tesla is no longer a hard to borrow (short) - so, in accordance with my core shorting tenet (of avoiding high short ...
Earnings reports continue to outperform, but can this support equity markets at these levels now?
The bears have predicted a negative reaction to earnings for many years and have seldom been rewarded for their pessimism. Microsoft will be a good test case Thursday.
There is still a very high level of interest in finding entry points -- it's not looking like a market that is ready to fall apart.
As Tesla and Microsoft earnings go this evening - so goes my Trade of the Week (Short at $265.50).
It will not collapse on valuation, fraud, currently non-existent inflation or its own weight. But here's what could knock it off its feet.
I would give consideration to some profit taking and/or raising stop protection.
Let's review the charts and indicators.
Various hard-charging mega-cap stocks seem overdue for a significant pause, while a drop in Acadia Pharmaceuticals sets up an options play.
The markets are really in the hands of Washington right now, and Washington is in the hands of the virus.
The magnitude of the large daily per share and market cap dollar gains in Tesla , Amazon , etc. is now comparable, and in certain cases more extreme, than what occurred in the dot.com era. What is forgotten is that large cap technology joined the s...
* It's the mother of all short squeezes (part deux) * Does he live under water? "Yeah, like Bizarro Superman, Superman's exact opposite, who lives in the backwards Bizarro world. Up is down, down is up, he says hello when he leaves, goodbye when he...
I expect Tesla to be added to the S&P in 2020. About $4 trillion of the S&P is indexed - that includes mutual funds and ETFs that replicate the Index. Tesla's market cap is about $300 billion - of which 18.5% is owned by Elon Musk. Therefore, the ...
Monday's rally might have been ugly, except that this is 2020. Anything goes in 2020.
You can bet on black, which is instant vaccine, or you can bet on red, which is the shutdown non-economy. Both have variants.
The Q2 growth is growth, but the weakest growth on record.
Could it be that money is beginning to flow from tech to consumer staples like this household name?
Think they don't ring a bell at the top? Then I've got an old Cisco chart I'd like to show you....
We may be seeing the beginning of a change in market leadership.